Publications by authors named "Lujan Forti"
Article Synopsis
- The study aimed to evaluate the prevalence of symptomatic hypoglycemic events and the achievement of HbA1c targets in patients with type 2 diabetes initiating basal insulin treatment.
- A total of 385 patients were assessed, revealing that 11.9% experienced hypoglycemia, and 31.6% reached their HbA1c target at 24 weeks.
- Those with hypoglycemia had a lower success rate in achieving glycemic targets compared to those without hypoglycemic events, highlighting a potential risk in managing diabetes with insulin.
[New generation of insulins: glargine U300. Summary of clinical evidence].
Medicina (B Aires)
September 2019
Type 2 diabetes is a chronic, progressive disease with increasing prevalence and still late diagnostic. This leads to an increase in the incidence of chronic complications, with signifi cantly increasing health costs. There is also a delay in the onset of insulin therapy in patients with type 2 diabetes for causes related to both patients and physicians.
View Article and Find Full Text PDFAim: To assess prescription patterns for treatment of type 2 diabetes (T2D) and their outcomes in the IDMPS survey in Argentina.
Methods: Data from 2551 people with T2D recruited from 210 physicians participating in IDMPS surveys in Argentina (2006 to 2012 waves) were recorded, including medical history, medications, glycemic control, blood pressure, and lipid status.
Results: Most people were treated with oral glucose-lowering drugs (OGLDs) (65%), followed by combinations of these drugs plus insulin (22%) and only insulin (13%).
Background: To evaluate the relation between different serum lipid fractions and other known barriers to attain the HbA ≤ 7.0% (53 mmol/mol) target.
Methods: Data on 2719 patients with type 2 diabetes were collected from the five waves of the International Diabetes Mellitus Practice Study implemented in Argentina (2006 to 2012) including demographic/socioeconomic profile, clinical, metabolic (HbA and serum lipids) data, and treatment type and also, percentage of treatment goal attainment.
Diabetes mellitus is a chronic metabolic disease characterized by the presence of hyperglycemia. This condition must be detected early in order to establish a proper treatment and prevent its micro and macro vascular complications. The diagnosis of diabetes mellitus is based on the detection of abnormally high levels of glycemia.
View Article and Find Full Text PDF